Advertisement

Topics

Rocket Pharma nets $59.5mm via FOPO

14:40 EST 30 Nov 2018 | Elsevier Business Intelligence

Rocket Pharmaceuticals Inc. (focused on developing gene therapies for rare pediatric diseases) netted $59.5mm through the fol...

Original Article: Rocket Pharma nets $59.5mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "Rocket Pharma nets $59.5mm via FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.